Atezolizumab: an investigational agent for the treatment of biliary tract cancer.
Saved in:
| Title: | Atezolizumab: an investigational agent for the treatment of biliary tract cancer. |
|---|---|
| Authors: | Hack SP; Product Development (Oncology), Genentech Inc, South San Francisco, CA, USA., Zhu AX; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Jiahui International Cancer Center, Jiahui Health, Shanghai, China. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Oct; Vol. 30 (10), pp. 1007-1015. Date of Electronic Publication: 2021 Sep 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-7658 |
|---|---|
| DOI: | 10.1080/13543784.2021.1974838 |
